*** Need an answer to your GCP query ? Post your query at HelpDesk ***
Follow us on
Process validation

Establishing by objective evidence that a process consistently produces a result or product meeting its predetermined specifications.
 Forums
Board Index Latest Posts Welcome Guest   [Register]  [Login]
EFGCP–EUCROF Joint Workshop Final Report   by  on 2010-08-20 12:12:20
Managing Clinical Trials   by  on 2010-07-15 16:05:32
US-FDA issues Revised Info Sheet Guidance on Clinical Investigator Disqualification   by  on 2010-06-13 10:11:41
US-FDA issues final guidance on Statement of Investigator (Form FDA 1572)   by  on 2010-06-13 10:07:59
Rising Clinical Trial Complexity Continues to Vex Drug Developers   by  on 2010-06-03 09:36:33
Investigator-Driven Clinical Trials: An ESF Forward Look   by  on 2010-06-03 09:27:58
NIH's Financial Conflict of Interest (FCOI) Proposed Rule   by  on 2010-05-27 11:42:00
AAP’s Guidelines for the Ethical Conduct of Studies to Evaluate Drugs in Pediatric Population   by  on 2010-05-13 11:39:54
Argentina: ANMAT - new regulatory update   by  on 2010-05-01 01:40:32
 Subject :US FDA Draft Guidance on Pharmacokinetics in Patients with Impaired Re.. 2010-03-20 12:25:16 
GCP HelpDesk
Moderator
Joined: 2009-06-18 15:31:58
Posts: 62
Location: 
Subject :US FDA Draft Guidance on Pharmacokinetics in Patients with Impaired Renal Function

Dear Friends,

US FDA issued Draft Guidance for Industry on Pharmacokinetics in Patients with Impaired Renal Function — Study Design, Data Analysis, and Impact on Dosing and Labeling. To access this document click here

Kind regards,

 
IP Logged
GCP HelpDesk
Page # 


Powered by ccBoard